Analyzing LogicMark (OTCMKTS:LGMKD) and Alphatec (NASDAQ:ATEC)

LogicMark (OTCMKTS:LGMKD – Get Free Report) and Alphatec (NASDAQ:ATEC – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, risk and valuation.

Profitability

This table compares LogicMark and Alphatec’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
LogicMark -90.21% -57.08% -44.90%
Alphatec -13.49% -6,752.24% -13.88%

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for LogicMark and Alphatec, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LogicMark 0 1 0 0 2.00
Alphatec 1 1 13 0 2.80

Alphatec has a consensus price target of $17.40, suggesting a potential upside of 69.76%. Given Alphatec’s stronger consensus rating and higher possible upside, analysts plainly believe Alphatec is more favorable than LogicMark.

Institutional & Insider Ownership

7.9% of LogicMark shares are held by institutional investors. Comparatively, 66.3% of Alphatec shares are held by institutional investors. 2.2% of LogicMark shares are held by insiders. Comparatively, 13.5% of Alphatec shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Risk & Volatility

LogicMark has a beta of 1.67, meaning that its share price is 67% more volatile than the S&P 500. Comparatively, Alphatec has a beta of 0.78, meaning that its share price is 22% less volatile than the S&P 500.

Valuation and Earnings

This table compares LogicMark and Alphatec”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
LogicMark $9.90 million 0.09 -$9.00 million ($94.52) -0.01
Alphatec $764.16 million 2.07 -$143.36 million ($0.71) -14.44

LogicMark has higher earnings, but lower revenue than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than LogicMark, indicating that it is currently the more affordable of the two stocks.

Summary

Alphatec beats LogicMark on 10 of the 14 factors compared between the two stocks.

About LogicMark

(Get Free Report)

LogicMark, Inc. provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The company’s devices provide people with the ability to receive care at home and age independently and to check, manage, and monitor a loved one’s health and safety remotely. It also manufactures and distributes non-monitored and monitored personal emergency response systems, which are offered through the United States Veterans Health Administration (VHA), direct-to-consumers, healthcare durable medical equipment dealers and distributors, monitored security dealers and distributors, and its ecommerce website logicmark.com and Amazon.com. The company was formerly known as Nxt-ID, Inc. and changed its name to LogicMark, Inc. in March 2022. LogicMark, Inc. was founded in 2006 and is based in Louisville, Kentucky.

About Alphatec

(Get Free Report)

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Receive News & Ratings for LogicMark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LogicMark and related companies with MarketBeat.com's FREE daily email newsletter.